This year, NeuroEndocrine Cancer Australia continued to expand our reach and impact thanks
to the incredible support of our community. Click below to read the 2025 Impact Report in full.
After 458 days of waiting, the Government finally released its response to the Senate Inquiry into Rare and Less Common Cancers, including Neuroendocrine Cancer, on
NECA recently attended a Rare Cancers Roundtable to discuss “The value of cancer clinical trials and setting up for success.” Attendees were diverse, including industry,
Each year on 10 November for World Neuroendocrine Cancer Day, NeuroEndocrine Cancer Australia joins the global movement to raise awareness of Neuroendocrine Tumours (NETs). This
NECA CEO Meredith Cummins attended Shane Kent’s post Arch2Arc event on Friday 19 September 2025 in Brisbane. It was such a great night where Shane’s family, friends
